A randomized phase 3 trial focused on patients with treatment-naive or relapsed/refractory disease.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/pirtobrutinib-shows-similar-efficacy-ibrutinib-cll-2025a1000yho?src=rss
Author :
Publish date : 2025-12-09 12:26:00
Copyright for syndicated content belongs to the linked Source.
